Aktive Positionen von Emmanuelle Charpentier
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
ERS Genomics Ltd.
 ERS Genomics Ltd. BiotechnologyHealth Technology ERS Genomic Ltd. engages in the development of biotechnology. It was formed to provide broad access to the foundational CRISPR-Cas9, a new genome editing technology, which offers speed, efficiency, and cost over earlier genome editing methods. The company was founded by Emmanuelle Charpentier and Shaun Foy in 2014 and is headquartered in Dublin, Ireland. | Gründer | 01.01.2014 | - |
| Corporate Officer/Principal | 01.01.2014 | - |
Karriereverlauf von Emmanuelle Charpentier
Ehemalige bekannte Positionen von Emmanuelle Charpentier
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CRISPR THERAPEUTICS AG | Gründer | 31.10.2013 | - |
Statistik
International
| Schweiz | 2 |
| Irland | 2 |
Operativ
| Founder | 2 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| Private Unternehmen | 1 |
|---|---|
ERS Genomics Ltd.
ERS Genomics Ltd. BiotechnologyHealth Technology ERS Genomic Ltd. engages in the development of biotechnology. It was formed to provide broad access to the foundational CRISPR-Cas9, a new genome editing technology, which offers speed, efficiency, and cost over earlier genome editing methods. The company was founded by Emmanuelle Charpentier and Shaun Foy in 2014 and is headquartered in Dublin, Ireland. | Health Technology |
- Börse
- Insiders
- Emmanuelle Charpentier
- Erfahrung
